ACE2 and COVID-19: Critically ill COVID-19 patients show a pulmonary hypercoagulable state [4,28,33,34] and it has been suggested that the proximity of type II alveolar epithelial cells expressing ACE2 to the pulmonary microvasculature could be the reason for the diffuse thrombotic events caused by the hyper inflammation.